期刊文献+

口服中成药说明书禁忌信息的调查

Investigation on Contraindicated Information of Oral Proprietary Chinese Medicines
下载PDF
导出
摘要 目的 分析口服中成药说明书的禁忌特点,为临床合理用药提供一些参考。方法 收集新乡医学院第一附属医院2022年1月1日至2023年8月31日常用的217份口服中成药说明书,计算配伍禁忌、证候禁忌、用药人群禁忌及饮食禁忌的标注率,分析禁忌特点。结果 标注“禁忌信息”的说明书占55.30%(120/217),其中“用药人群禁忌”的标注率最高,为48.85%(106/217);“配伍禁忌”的标注率最低,为1.38%(3/217)。“孕妇禁用、慎用、忌用或在医生指导下服用”的标注率最高,为81.13%(86/106);“青春期及更年期在医生指导下服用”的标注率最低,为1.89%(2/106)。结论 临床用药需详细阅读禁忌信息,便于合理安全使用中成药。 Objective The contraindications of oral Chinese patent medicine instructions were analyzed to provide some references for clinical rational drug use.Methods A total of 217 instructions of oral proprietary Chinese medicines used in the First Affiliated Hospital of Xinxiang Medical University from January 1,2022 to August 31,2023 were collected.The labeling rates of incompatibility,syndrome contraindications,drug population contraindications and dietary contraindications were calculated,and the contraindications were analyzed.Results The instructions marked with“contraindicated information”accounted for 55.30%(120/217),and among which,48.85%(106/217)of the instructions marked with“drug population contraindicated”,which was the highest,the labeling rate of“incompatibility”was the lowest[1.38%(3/217)].The labeling rate of“forbidden,cautiously used,contraindicated or under the guidance of doctors in pregnant women”was the highest[81.13%(86/106)].The labeling rate of“adolescent and menopause should be taken under the guidance of doctors”was the lowest[1.89%(2/106)].Conclusion It is necessary to read the contraindicated information in detail for the rational and safe use of proprietary Chinese medicine.
作者 袁红昌 蔡爱琴 王晓光 刘俊闯 王银砾 张志亮 YUAN Hongchang;CAI Aiqin;WANG Xiaoguang;LIU Junchuang;WANG Yinli;ZHANG Zhiliang(Department of Clinical Pharmacy,the First Affiliated Hospital of Xinxiang Medical University,Xinxiang 453100,China;Key Medical Disciplines of Henan Province(Clinical Pharmacy),the First Affiliated Hospital of Xinxiang Medical University,Xinxiang 453100,China;Xinxiang Key Laboratory of Personalized Medicine for Immune Diseases,the First Affiliated Hospital of Xinxiang Medical University,Xinxiang 453100,China;Department of Infection Prevention and Control,the First Affiliated Hospital of Xinxiang Medical University,Xinxiang 453100,China)
出处 《河南医学研究》 CAS 2024年第20期3649-3653,共5页 Henan Medical Research
关键词 中成药 药品说明书 临床 禁忌 调查 proprietary Chinese medicine drug instructions clinical contraindication survey
  • 相关文献

参考文献13

二级参考文献124

共引文献116

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部